gout supplementary data appendix a
TRANSCRIPT
-
7/25/2019 Gout Supplementary Data Appendix A
1/1
1
Supplemental Appendix A:
Conflict of interest (COI)
Specific relationships with companies, and respective pharmaceuticals in use representing COI,
were: URL Pharma (Colchicine); Takeda (Febuxostat); Amgen / Biovitrum / Sobi (Anakinra);
Savient (Pegloticase). Specific relationships with companies, and respective pharmaceuticals inclinical trials representing COI, were: Celgene (Apremilast); AstraZeneca (AZD6140); BioCryst
(BCX4208); Merck (Etoricoxib); Novartis (Canakinumab, Lumaricoxib); Ardea Biosciences
(Lesurinad); Regeneron (Rilonacept); Glaxo Smith Kline and Nuon Therapuetics (Tranilast);EnzymeRx (Pegadricase).